Plain-English translation of NCT05491577 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is an observational study — meaning researchers will follow patients with Charcot foot over time rather than test a new medication. Charcot foot is a serious diabetes complication that damages bones, joints, and soft tissues in the foot and ankle, and it's still not well understood by patients or doctors. The study aims to identify which factors most affect quality of life in people living with this condition, so doctors can better predict who will struggle most and provide better support.
Charcot foot is often diagnosed late or missed entirely, and very little is known about how it impacts daily life over time. This study will help doctors understand what causes quality of life to worsen — whether it's loss of foot function, deformity, other diabetes complications, or something else — so they can identify patients who need the most help and provide better care.
You likely qualify if…
You likely don't qualify if…
You would be followed by the research team for 2 years as part of a French multicenter study. During this time, researchers will assess how your quality of life changes, check your foot function and any deformities, review your diabetes care, and ask about other health conditions. The study does not involve testing a new drug — instead, it gathers information from your medical visits and your own reports to understand what factors most affect how people with Charcot foot live day to day.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
France